Fiche centre
Princess Margaret Hospital
Toronto — Canada
Essais liés4clinical trials
VilleTorontolocalisation
PaysCanadalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07164443
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Rituximab | SEP | Phase 3 | NCT00004179 | Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | COMPLETED |
| Pre-treatment tumour oxygen measurements | Cancer | Phase 2 | NCT00160979 | Transrectal Tumour Oxygen - US Army | COMPLETED |
| Pasritamig | Cancer | Phase 3 | NCT07164443 | KLK2-comPAS — A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) | RECRUITING |
| MRI Targeted Focal Thermal Therapy of Prostate Cancer | Cancer | Phase 1 | NCT00448695 | MRI Targeted Focal Laser Thermal Therapy of Biopsy Confirmed Prostate Cancer | COMPLETED |